Geriatrics Clinical Trials in Metairie, LA
As of June 2026, 2 paid clinical trials are recruiting for Geriatrics in Metairie, Louisiana. Geriatrics trials test interventions for frailty, sarcopenia, cognitive decline, and falls — alongside disease-modifying therapies for Alzheimer's and age-related conditions affecting older adults. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
2 clinical trials for Geriatrics
·Clear filters·↓ Download CSVClinical Trial on Agitation in Alzheimer's Dementia
About research studies in Metairie
Metairie has approximately 87 recruiting research studies across a wide range of therapeutic areas. Louisiana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Metairie
Researchers run research studies in Metairie, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| East Jefferson General Hospital | Stage IV Renal Cell Cancer AJCC v8, Metastatic Renal Cell Carcinoma, Recurrent Endometrial Carcinoma | 19 |
| LSU Healthcare Network / Metairie Multi-Specialty Clinic | Stage IV Renal Cell Cancer AJCC v8, Metastatic Renal Cell Carcinoma, Prostate Adenocarcinoma | 13 |
| Mary Bird Perkins Cancer Center - Metairie | Muscle Invasive Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v8, Locally Advanced Urothelial Carcinoma | 9 |
| Clinical Trials Management, LLC | Hidradenitis Suppurativa (HS), Atopic Dermatitis (AD), Ulcerative Colitis | 4 |
| GI Alliance | Crohn's Disease, Ulcerative Colitis, Celiac Disease | 4 |
| Tandem Clinical Research | COPD, Major Depressive Disorder, Metabolic Dysfunction-Associated SteatoHepatitis (MASH) | 4 |
| Omega Clinical Research | Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Disease and Lipoprotein(a) | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| East Jefferson Hospital | Oligometastatic Prostate Cancer (OMPC), Prostate Cancer | 2 |
| MedCentris of Metairie | Open Wound, Venous Leg Ulcer | 2 |
| Southern Clinical Research Associates | Endometrial Hyperplasia, Preeclampsia (PE) | 2 |
| Tandem Clinical Research - Metairie Clinic | Gout, Tophaceous Gout | 2 |
| Clinical Trials Management | Plaque Psoriasis | 1 |
| Clinical Trials Management - Metairie- Site Number : 8400072 | Acne | 1 |
| Clinical Trials Management, LLC d/b/a Flourish Research | Obesity, Overweight | 1 |
| Coleman Center For Cosmetic Dermatologic Surgery | Moderate to Severe Glabellar Lines | 1 |
| Crinetics Study Site | Neuroendocrine Neoplasm, Neuroendocrine Tumors, SST2-positive Neuroendocrine Neoplasms | 1 |
| Exelixis Clinical Site #23 | Extra-Pancreatic Neuroendocrine Tumor (epNET), Pancreatic Neuroendocrine Tumor (pNET) | 1 |
| GI Alliance - Metairie - Site Number: 8400124 | Ulcerative Colitis | 1 |
| GI Alliance - Metairie-Site Number: 8400124 | Crohn's Disease | 1 |
| LA Center for Bleeding and Clotting Disorders - Metairie | Factor VII Deficiency, Healthy Participants, Hemophilia A | 1 |
| LCMC Health | Proteinuric Kidney Disease | 1 |
| Local Institution - 0202 | Plaque Psoriasis | 1 |
| Louisiana State University Health Sciences | Carcinoid, Carcinoid Intestine Tumor, Carcinoid Syndrome | 1 |
| Mary Bird Cancer Center | Prostate Adenocarcinoma | 1 |
Active & Upcoming Studies in Metairie (2026)
Recruiting trials in Metairie grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (30 active studies)
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · Phase 3 · AstraZeneca
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (5 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
Neurology & pain (3 active studies)
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease · Phase 2 · Lighthouse Pharmaceuticals, Inc.
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS · Phase 2 · Vaneltix Pharma, Inc.
Cardiovascular (2 active studies)
Eye & vision (2 active studies)
- A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio · Phase 2 · Apellis Pharmaceuticals, Inc.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Common conditions studied in Metairie
- Ulcerative Colitis (4 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- Crohn's Disease (3 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Prostate Adenocarcinoma (3 active studies). Recruiting Prostate Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IV Renal Cell Cancer AJCC v8 (3 active studies). Recruiting Stage IV Renal Cell Cancer AJCC v8 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Alzheimer Disease (2 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Graves' Disease (2 active studies). Recruiting Graves' Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Metairie
- National Cancer Institute (NCI)
- NRG Oncology
- Novartis Pharmaceuticals
- SWOG Cancer Research Network
- AstraZeneca
Local regulations and guidelines
Clinical trials in Louisiana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Louisiana research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Metairie. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Metairie
Hipa.ai aggregates every recruiting study in Metairie from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Metairie?
There are approximately 87 recruiting clinical trials in Metairie, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Metairie pay participants?
Most recruiting trials in Metairie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Metairie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Metairie?
The most common conditions under active study in Metairie include Ulcerative Colitis (4), Crohn's Disease (3), Prostate Adenocarcinoma (3), Stage IV Renal Cell Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Metairie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Metairie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Metairie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Metairie?
Recruiting research sites in Metairie include East Jefferson General Hospital, LSU Healthcare Network / Metairie Multi-Specialty Clinic, Mary Bird Perkins Cancer Center - Metairie, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Metairie right now?
The largest active categories in Metairie are Cancer & tumors (30), Diabetes & metabolic (5), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.